MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202641008856 A) filed by Mohan Babu University; and Dr. S. Varalaxmi, Tirupati, Andhra Pradesh, on Jan. 29, for 'palbociclib-loaded liposomal nanocarrier system for targeted and controlled breast cancer therapy.'
Inventor(s) include Dr. S. Varalaxmi; Mr. Annem Venkata Dhanush Kumar Reddy; Ms. Bangi Amrutha; Ms. Bodugu Bhargavi; Ms. Bukke Reshika; and Mr. Busineni Reddy Raja.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The invention discloses a Palbociclib-loaded liposomal drug delivery system (100) designed for targeted and sustained release in breast cancer therapy. The system comprises a lipid phase (110) of soy phosphatidylcholine and a stabilizer (120) of cholesterol encapsulating Palbociclib (130) within nanovesicular bilayers. The formulation is prepared by thin-film hydration, followed by sonication (150) to produce nanosized vesicles exhibiting uniform morphology, optimal stability, and high entrapment efficiency. Analytical characterization by FTIR, DSC, and TEM confirms compatibility and encapsulation integrity. The resulting liposomes show enhanced bioavailability, sustained release, and reduced systemic toxicity, making them a promising therapeutic platform for effective breast cancer management."
Disclaimer: Curated by HT Syndication.
